Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Discloses Dako Earnings

NEW YORK (GenomeWeb News) – Through eight months ending May 31, 2012, Dako posted $242 million in revenues, Agilent Technologies disclosed in a regulatory filing after the close of the market on Wednesday, which also disclosed Dako's earnings for full-year 2011 and for the six months ended March 31.

Agilent completed its $2.2 billion purchase of the Danish cancer diagnostics company in June.

In a document filed with the US Securities and Exchange Commission on Wednesday, Agilent said that Dako had a net loss of $61 million on a GAAP basis for the eight months ended May 31. R&D spending during the period totaled $37 million and SG&A costs were $100 million.

During the six months ended March 31, Dako posted revenues of $183 million and a net loss of $23 million. It spent $24 million on R&D and $76 million on SG&A. In full-year 2011, the firm had a loss of $43 million on revenues of $361 million. R&D spending was $51 million for FY 2011, while SG&A spending was $155 million.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.